First Time Loading...

Aveo Pharmaceuticals Inc
NASDAQ:AVEO

Watchlist Manager
Aveo Pharmaceuticals Inc Logo
Aveo Pharmaceuticals Inc
NASDAQ:AVEO
Watchlist
Price: 15 USD
Updated: Jun 10, 2024

Aveo Pharmaceuticals Inc
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aveo Pharmaceuticals Inc
Net Change in Cash Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Aveo Pharmaceuticals Inc
NASDAQ:AVEO
Net Change in Cash
$8.6m
CAGR 3-Years
-39%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Net Change in Cash
$11.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
26%
Gilead Sciences Inc
NASDAQ:GILD
Net Change in Cash
-$218m
CAGR 3-Years
67%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Net Change in Cash
-$21.9B
CAGR 3-Years
-140%
CAGR 5-Years
-56%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Change in Cash
-$126.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Change in Cash
-$1.3B
CAGR 3-Years
-20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Aveo Pharmaceuticals Inc's Net Change in Cash?
Net Change in Cash
8.6m USD

Based on the financial report for Sep 30, 2022, Aveo Pharmaceuticals Inc's Net Change in Cash amounts to 8.6m USD.

What is Aveo Pharmaceuticals Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
17%

Over the last year, the Net Change in Cash growth was -70%. The average annual Net Change in Cash growth rates for Aveo Pharmaceuticals Inc have been -39% over the past three years , 17% over the past five years .